Crossmark

Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer

Crossref DOI link: https://doi.org/10.1007/s00259-021-05296-1

Published Online: 2021-03-13

Published Print: 2021-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Malaspina, Simona https://orcid.org/0000-0002-2701-8978
Anttinen, Mikael

Taimen, Pekka

Jambor, Ivan

Sandell, Minna

Rinta-Kiikka, Irina

Kajander, Sami

Schildt, Jukka

Saukko, Ekaterina

Noponen, Tommi

Saunavaara, Jani

Dean, Peter B.

Sequeiros, Roberto Blanco

Aronen, Hannu J.

Kemppainen, Jukka

Seppänen, Marko

Boström, Peter J.

Ettala, Otto
Funding

Funding for this research was provided by:

Finnish Government Research and Development Funds for Medical Research, Turku University Hospital

TYKS-SAPA Research Fund
License Information

Text and Data Mining valid from 2021-03-13

Version of Record valid from 2021-03-13
More Information

Article History

Received: 3 December 2020

Accepted: 28 February 2021

First Online: 13 March 2021

Declarations

:

: The study received approval from the Ethical Committee of South West Finland (Dnro:26/1801/2018).

: All patients signed written consent prior to the initiation of the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below